Berlin Registry of Right Heart Interventions

Status Recruiting

Clinical Trial Summary

The present study evaluates patients after interventional therapy of valvular diseases of the right heart. Follow-up examinations include medical history taking, laboratory measurements and an echo. The aim is to assess the different interventional therapies and their impact on patient's outcome.

Clinical Trial Description

The subject of the study is to register interventional therapies of right heart diseases (such as "cardioband" and "edge-to-edge" techniques of the tricuspid valve) performed in Berlin/ Brandenburg (primarily at the Charité, Universitätsmedizin Berlin). Based on the development and the increasing use of interventional therapies in tricuspid and pulmonary valve diseases, the impact on the patients' symptoms and life expectancy after interventions will be investigated. The aim is to identify patient subgroups that benefit the most. Primary endpoints: Total mortality, cardiovascular mortality, heart failure hospitalization. Secondary endpoints: NYHA class, NTproBNP, liver and kidney function (laboratory measurements), valve function, cardiac function, and cardiac morphology. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04570163
Study type	Observational [Patient Registry]
Source	Charite University, Berlin, Germany
Contact	Henryk Dreger, Prof. Dr. med.
Phone	+4930450613496
Email	henryk.dreger@charite.de
Status	Recruiting
Phase
Start date	June 16, 2020
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05434507` - Feasibility Study of Treating Tricuspid Regurgitation With K-ClipTM Transcatheter Annuloplasty System	N/A
Completed	`NCT03144024` - Comparison of Rigid Annuloplasty Ring With a Band in the Correction of Secondary Tricuspid Insufficiency	N/A
Enrolling by invitation	`NCT05825898` - Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment
Completed	`NCT05836493` - Very Long-term (>15 Years) Results of Tricuspid Valve Repair.
Enrolling by invitation	`NCT06033274` - Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
Recruiting	`NCT05671640` - Feasibility Study of the DragonFly-T System for Severe Tricuspid Regurgitation	N/A
Recruiting	`NCT06027307` - Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation	Phase 3
Terminated	`NCT04665583` - Prehab Prior to Undergoing Tricuspid Intervention
Recruiting	`NCT06307262` - European Registry of Transcatheter Repair for Tricuspid Regurgitation
Completed	`NCT02981953` - TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System	N/A
Recruiting	`NCT04433065` - TTVR Early Feasibility Study	N/A
Not yet recruiting	`NCT05556460` - Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation	N/A
Recruiting	`NCT05667519` - Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation (PLACE)	N/A
Recruiting	`NCT04653428` - German Registry for Transcatheter Tricuspid Valve Interventions
Recruiting	`NCT05179616` - Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair
Completed	`NCT02644616` - The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement	Phase 4
Recruiting	`NCT05328284` - PASCAL for Tricuspid Regurgitation - a European Registry
Completed	`NCT02675244` - Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery	N/A
Recruiting	`NCT05436028` - A Study to Evaluate the Safety and Performance of LuX-Valve Plus System for Tricuspid Replacement	N/A
Completed	`NCT01093001` - Tricuspid Regurgitation Study	Phase 4